|
SERINC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82449999552858E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.441200E-03 |
| Normal-vs-Stage2 |
6.843700E-02 |
| Normal-vs-Stage3 |
2.48130005431335E-09 |
| Normal-vs-Stage4 |
2.31069607892209E-11 |
| Stage1-vs-Stage2 |
5.753000E-01 |
| Stage1-vs-Stage3 |
2.218600E-04 |
| Stage1-vs-Stage4 |
1.69289999996103E-06 |
| Stage2-vs-Stage3 |
1.835030E-01 |
| Stage2-vs-Stage4 |
3.711600E-02 |
| Stage3-vs-Stage4 |
1.864040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.41209999646475E-08 |
| Normal-vs-AfricanAmerican |
4.841300E-04 |
| Normal-vs-Asian |
8.283700E-03 |
| Caucasian-vs-AfricanAmerican |
8.741800E-01 |
| Caucasian-vs-Asian |
7.353000E-01 |
| AfricanAmerican-vs-Asian |
7.373400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.73520003815742E-09 |
| Normal-vs-Female |
5.442400E-04 |
| Male-vs-Female |
6.506300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.759700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.57939999999979E-05 |
| Normal-vs-Age(61-80Yrs) |
6.33969999830342E-08 |
| Normal-vs-Age(81-100Yrs) |
1.994220E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.095000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.306000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.490400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.414400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.845800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.198400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.646400E-02 |
| Normal-vs-Grade 2 |
6.853900E-02 |
| Normal-vs-Grade 3 |
7.36819494306928E-11 |
| Normal-vs-Grade 4 |
1.4432899320127E-15 |
| Grade 1-vs-Grade 2 |
7.615700E-02 |
| Grade 1-vs-Grade 3 |
1.022980E-04 |
| Grade 1-vs-Grade 4 |
4.0365000009146E-08 |
| Grade 2-vs-Grade 3 |
1.63751999999739E-05 |
| Grade 2-vs-Grade 4 |
2.03469463500028E-11 |
| Grade 3-vs-Grade 4 |
4.031700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.565600E-01 |
| Normal-vs-ccB subtype |
4.66293670342566E-15 |
| ccA subtype-vs-ccB subtype |
1.7142953723237E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.15980000000316E-05 |
| Normal-vs-N1 |
1.965090E-04 |
| N0-vs-N1 |
1.187960E-02 |
|
|
